GASK1A

Across TCGA pan-cancer cohorts, GASK1A Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GASK1A data layer compared with 22 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher GASK1A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GASK1A expression acts as an unfavorable survival marker.

OV, COAD, and KICH are the cancer types where GASK1A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	II,III,IV	0.022	0.844	<.001	48	view →
COAD	OS	Median	All	0.111	0.871	<.001	18	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

GASK1A–OV (OS)

Open the OV breakdown →